Consolidated Statements of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2012
Income Statement [Abstract]
Revenue	$ 91,084		$ 101,093		$ 107,552
Cost of products sold	85,923		96,172		103,011
Gross margin	5,161		4,921		4,541
Operating expenses:
Distribution, selling, general and administrative expenses	3,028		2,875		2,677
Restructuring and employee severance	31	[1]	71	[2]	21
Amortization and other acquisition-related costs	223		158		33
Impairments and loss on disposal of assets	15		859		21
Litigation (recoveries)/charges, net	(21)		(38)		(3)
Operating earnings	1,885		996		1,792
Other income, net	(46)		(15)		(1)
Interest expense, net	133		123		95
Earnings before income taxes and discontinued operations	1,798		888		1,698
Provision for income taxes	635		553		628
Earnings from continuing operations	1,163		335		1,070
Earnings/(loss) from discontinued operations, net of tax	3		(1)		(1)
Net earnings	$ 1,166		$ 334		$ 1,069
Basic earnings per common share:
Continuing operations	$ 3.41		$ 0.98		$ 3.10
Discontinued operations	$ 0.01		$ 0.00		$ 0.00
Net basic earnings per common share	$ 3.42		$ 0.98		$ 3.10
Diluted earnings per common share:
Continuing operations	$ 3.37		$ 0.97		$ 3.06
Discontinued operations	$ 0.01		$ 0.00		$ 0.00
Net diluted earnings per common share	$ 3.38		$ 0.97		$ 3.06
Weighted-average number of common shares outstanding:
Basic	341		341		345
Diluted	345		344		349

[1] Includes $10 million of primarily facility exit and other costs related to the restructuring within our Medical segment described further below.

[2] Includes $30 million of employee-related costs and $10 million of facility exit and other costs related to the restructuring within our Medical segment described further below.